Raphael Deferiere insider trades
Open-market stock purchases and sales by Raphael Deferiere, Chief Accounting Officer at Centessa Pharmaceuticals plc, from SEC Form 4 filings since Jun 2, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Sold (not open market) | — |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Sold (not open market) | $2.2M |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Sold (not open market) | $1.1M |
| Feb 2, 2026 | CNTA Centessa Pharmaceuticals plc | Bought (not open market) | — |
| Feb 2, 2026 | CNTA Centessa Pharmaceuticals plc | Bought (not open market) | — |
Companies traded
- CNTA Centessa Pharmaceuticals plc: other filings, last Jun 24, 2026